Trexquant Investment’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-74,781
| Closed | -$2M | – | 1632 |
|
|
2024
Q4 | $2M | Buy |
+74,781
| New | +$2M | 0.02% | 863 |
|
|
2024
Q2 | – | Sell |
-126,332
| Closed | -$2.3M | – | 1608 |
|
|
2024
Q1 | $2.3M | Buy |
126,332
+70,741
| +127% | +$1.29M | 0.05% | 593 |
|
|
2023
Q4 | $608K | Buy |
+55,591
| New | +$608K | 0.01% | 1004 |
|
|
2023
Q1 | – | Sell |
-32,014
| Closed | -$286K | – | 1530 |
|
|
2022
Q4 | $286K | Buy |
32,014
+14,752
| +85% | +$132K | 0.01% | 1120 |
|
|
2022
Q3 | $170K | Sell |
17,262
-12,409
| -42% | -$122K | 0.01% | 1226 |
|
|
2022
Q2 | $236K | Buy |
29,671
+7,459
| +34% | +$59.3K | 0.01% | 1259 |
|
|
2022
Q1 | $215K | Buy |
22,212
+8,189
| +58% | +$79.3K | 0.01% | 1168 |
|
|
2021
Q4 | $214K | Buy |
+14,023
| New | +$214K | 0.01% | 1114 |
|